論文

査読有り
2018年5月1日

Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan

Cancer Medicine
  • Masashi Mizumoto
  • ,
  • Shigeyuki Murayama
  • ,
  • Tetsuo Akimoto
  • ,
  • Yusuke Demizu
  • ,
  • Takashi Fukushima
  • ,
  • Yuji Ishida
  • ,
  • Yoshiko Oshiro
  • ,
  • Haruko Numajiri
  • ,
  • Hiroshi Fuji
  • ,
  • Toshiyuki Okumura
  • ,
  • Hiroki Shirato
  • ,
  • Hideyuki Sakurai

7
5
開始ページ
1870
終了ページ
1874
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1002/cam4.1464
出版者・発行元
Blackwell Publishing Ltd

To evaluate preliminary results of proton radiotherapy (PRT) for pediatric patients with rhabdomyosarcoma (RMS). From 1987 to 2014, PRT was conducted as initial radiotherapy in 55 patients (35 males, 20 females, median age 5 years, range 0–19) with RMS at four institutes in Japan. Thirty-one, 18, and six patients had embryonal, alveolar, and other RMS, respectively. One, 11, 37, and six patients were in IRSG groups I, II, III, and IV, respectively, and the COG risk group was low, intermediate, and high for nine, 39, and seven patients, respectively. The irradiation dose was 36–60 GyE (median: 50.4 GyE). The median follow-up period was 24.5 months (range: 1.5–320.3). The 1- and 2-year overall survival rates were 91.9% (95% CI: 84.3–99.5%) and 84.8% (95% CI 75.2–94.3%), respectively, and these rates were 100% and 100%, 97.1% and 90.1%, and 57.1% and 42.9% for COG low-, intermediate-, and high-risk groups, respectively. There were 153 adverse events of Grade ≥3, including 141 hematologic toxicities in 48 patients (87%) and 12 radiation-induced toxicities in nine patients (16%). Proton-specific toxicity was not observed. PRT has the same treatment effect as photon radiotherapy with tolerable acute radiation-induced toxicity.

リンク情報
DOI
https://doi.org/10.1002/cam4.1464
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29605967
ID情報
  • DOI : 10.1002/cam4.1464
  • ISSN : 2045-7634
  • PubMed ID : 29605967
  • SCOPUS ID : 85044681801

エクスポート
BibTeX RIS